期刊文献+

APPL1对高糖及炎症因子诱导的胰岛β细胞凋亡和功能损伤的保护作用 被引量:2

The protective effect of APPL1 on high glucose or cytokines-induced pancreatic β-cell apoptosis and dysfunction
原文传递
导出
摘要 目的 明确适配蛋白APPL1在胰岛β细胞中的作用。方法 采用腺病毒转染使INS-1细胞过表达APPL1。Western印迹法检测蛋白表达水平,碘化丙啶/Hoechst染色法检测细胞凋亡,用ELISA检测胰岛素分泌。结果 20 mmol/L葡萄糖或30 U/ml白细胞介素-1β加20 ng/ml TNF-α作用INS-1细胞48 h后,可明显诱导胰岛β细胞凋亡(P〈0.01),并降低2 h葡萄糖刺激的胰岛素分泌水平(P〈0.01)。INS-1细胞过表达APPL1后,与各自的对照病毒组相比,APPL1可使细胞凋亡降低34.16%~42.79%(P〈0.01),并使葡萄糖刺激的胰岛素分泌升高至对照组的1.39~2.20倍(P〈0.05)。结论 APPL1对高糖和炎症因子诱导的胰岛β细胞损伤具有保护作用,可降低β细胞凋亡并改善葡萄糖刺激的胰岛素分泌。 Objective To determine the role of APPL1, an adaptor protein, played in pancreatic β-cell. MethodsAPPL1 was overexpressed in INS-1 cells with adenovirus encoding APPL1. Western blot was conducted to measure protein expression. Propidium iodide/Hoechst staining was used to determine the cell apoptosis. Insulin secretion was measured by ELISA. ResultsExposure of INS-1 cells to 20 mmol/L glucose or 30 U/ml interleukin-1 β plus 20 ng/ml TNF-α 48 h induced β-cell apoptosis (P〈0.01) and impaired 2 h glucose-stimulated insulin secretion (P〈0.01). Overexpression of APPL1 in INS-1 decreased cell apoptosis by 34.16%-42.79% (P〈0.01) and increased glucose-induced insulin secretion by 1.39-2.20 folds compared with control groups (P〈0.05). ConclusionAPPL1 decreases β-cell apoptosis and increases glucose-stimulated insulin secretion, and thus protects β-cell against high glucose or cytokines-induced dysfunction.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2013年第5期422-426,共5页 Chinese Journal of Endocrinology and Metabolism
基金 国家自然科学基金项目(30971121) 上海市科技创新重点项目(11140900900)
关键词 APPL1 细胞凋亡 胰岛素分泌 APPL1 Cell apoptosis Insulin secretion
  • 相关文献

参考文献19

  • 1Mao X, Kikani CK, Riojas RA, et al. APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat Cell Biol, 2006,8:516-523.
  • 2Wang C, Li L, Zhu YX, et al. Deficiency of APPL1 expression impaired adiponectin and glucose induced insulin secretion from beta- cells. IDF2011, World Diabetes Congress, Abstract: 0-0565.
  • 3Holland WL, Miller RA, Wang ZV, et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med, 2011,17:55-63.
  • 4Qiu Y, Mao T, Zhang Y, et al. A crucial role for RACK1 in the regulation of glucose-stimulated IREI alpha activation in pancreatic beta cells. Sci Signal, 2010,3 : ra7.
  • 5Darling A J, Boose JA, Spaltro J. Virus assay methods : accuracy and validation. Biologicals, 1998,26 : 105-110.
  • 6Wang C, Ling Z, Pipeleers D. Comparison of cellular and medium insulin and GABA content as markers for living beta-cells. Am J PhysiolEndocrinol Metab, 2005,288 : E307-E313.
  • 7尹德超,李羚,张明亮,李晓雯,王士洪,幕开达,王琛,贾伟平.流式细胞仪分选大鼠胰岛β细胞方法的建立及应用[J].诊断学理论与实践,2012,11(3):263-268. 被引量:2
  • 8袁凌青,廖二元.糖尿病治疗的新靶点:胰岛β细胞量[J].中华内分泌代谢杂志,2009,25(3). 被引量:6
  • 9Deepa SS, Dang LQ. APPLI: role in adiponectin signaling and beyond. Am J Physiol Endocrinol Metab, 2009,296 :E22-E36.
  • 10Cheng KK, Iqlesias MA, Lam KS, et al. APPL1 potentiates insulin- mediated inhibition of hepatic glucose production and alleviates diabetes via Akt activation in mice. Cell Metab, 2009,9:417-427.

二级参考文献54

  • 1Ritzel RZ.Therapeutic approaches based on beta-cell mass preservation and/or regeneration.Front Biosci,2009,14:1835-1850.
  • 2Maelean N,Ogilvie IF.Quantitative estimation of the pancreatic islet tissue in diabetic subects.Diabetes,1955,4:367-376.
  • 3Cnop M,Welsh N,Jonas JC,et al.Meehanisms of pancreatic beta-cell death in typel and type 2 diabetes:many differences,few similarities.Diabetes,2005,54(Suppl 2):S97-S107.
  • 4Butler AE,Janson J,Bonner-Weir S,et al.13-cell deficit and increased β-cell apoptosis in humans with type 2 dabetes.Diabetes,2003,52:102-110.
  • 5Sherry NA,Tsxi EB,Herold KC.Natural history of β-cell function in type 1 diabetes.Diabetes,2005,54 (Suppl 1):S25-S31.
  • 6yon Herrath M,Sanda S,Herold K.Type 1 diabetes as a relapsingremitting disease? Nat Rev Immuno;,2007,7:988-994.
  • 7Akirav E,Kushner JA,Herold KC.Beta-cell mass and type 1 diabetes:going,going,gone? Diabetes,2008,57:2883-2888.
  • 8Sakuraba B,Mizukami H,Yagihashi N,et al.Reduced β-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type Ⅱ diabetes mellitus.Diabetologia,2002,45:85-96.
  • 9Yoon KH,Ko SH,Cho JH,et al.Selective β-cell loss and β-cell expansion in patients with type 2 diabetes mellitus in Korea.J Clin Endcorinol Metab,2003,88:2300-2308.
  • 10Saudek F,Brogren CH,Manohar S.Imaging the β-cell mass:why and how.Key Diabet Stud,2008,5:6-12.

共引文献6

同被引文献23

  • 1成扬,平键,徐列明,刘成,谭英姿,陈高峰.姜黄素上调PPARγ抑制肝星状细胞活化标志表达的研究[J].中国实用内科杂志:临床前沿版,2006,26(12):1937-1940. 被引量:17
  • 2MAO X. KIKANI C K. RIO] AS R A. et al. APPU binds to adiponectin receptors and mediates adiponectin signalling and function[J]. Nat Cell Biol , 2006. 8(5): 516-523.
  • 3CHAPMAN H. WACLAW R R. PEl Z. et al. The homeobox gene Gsx2 controls the timing of oligodendroglial fate specification in mouse lateral ganglionic eminence progenitors[J]. Development. 2013. 140(11): 2289-2298.
  • 4LI L, LI X, ZHU v, et al. Growth receptor binding protein 10 inhibits glucose-stimulated insulin release from pancreatic -cells associated with suppression of the insulin/insulin-like growth Iactor-I signalling pathway[J]. Clin Exp Pharmacol Physiol , 2013, 40(12): 841-847.
  • 5VERHEIJDEN S. BECKERS L. DE MUNTER S, et al. Central nervous system pathology in MFP2 deficiency: insights from general and conditional knockout mouse models[J]. Biochimie , 2014. 98: 119-126.
  • 6BINDELS EM. VAN DEN BREKEL M W. Development of a conditional mouse model for head and neck squamous cell carcinoma[J]. Adv Otorhinolaryngol , 2005. 62: 1-11.
  • 7PORTER A. Controlling your losses: conditional gene silencing in mammals[J]. Trends Genet. 1998. 14(2): 73- 79.
  • 8LE Y. SAUER B. Conditional gene knockout using ere recombinase[J]. Methods Mol Biol 2000, 136: 477-485.
  • 9CUIJ, WANG Z. CHENG Q, et al. Targeted inactivation of kinesin-I in pancreatic -cells in vivo leads to insulin secretory deficiency[J]. Diabetes, 2011, 600): 320-330.
  • 10CHAKRAVARTHY M V, PAN Z, ZHU v , et al. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis[J]. Cell Metab, 2005. 1 ( 5) : 309-322.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部